Forty-eight patients with a clinical diagnosis of Alzheimer's disease, 30 patients with cerebrovascular dementia, and 48 normal controls were assessed with a battery of neuropsychological tests designed to measure the following cognitive processes: orientation to time and place, memory, visual-perceptual and constructional skills, language, conceptualization, attention, and executive functions (planning, self-regulation and fine motor coordination). The differences detected were in orientation to time and place, in immediate and delayed recall of a short story, and in naming in which the patients with Alzheimer's disease were significantly disadvantaged. Vice versa, in attention processes, self-regulation, planning, and fine motor coordination tasks the patients with cerebrovascular dementia were more severely impaired; these disturbances resemble some of those occurring in frontal lobe syndromes.

No abstract

In a group of 83 normal adults, spatial memory performance in the Block-Tapping Test depended not only on path length but also on digit sequence, which, for a given path length, generates different spatial configurations. Sequences of homogeneous difficulty are proposed for defining the spatial span.

To assess the validity of Raven's Colored Progressive Matrices (RCPM) as a measure of intellectual impairment after focal brain damage, we compared the performance of 24 right brain-damaged patients, 24 left brain-damaged patients (10 non-aphasic and 15 aphasic) and 20 controls on the RCPM. In addition to the total, we analyzed the scores obtained on each of the three sets in which the 36 items of the test could be categorized on the grounds of the cognitive ability mainly involved for their solution. The first set, which calls for the identification of sameness, posed special problems to RBD patients. The second set, which involves the principle of symmetry, was selectively failed by aphasic patients. The third set, which is more demanding in terms of analogical and conceptual thinking, was poorly performed by left brain-damaged patients, aphasics as well as non-aphasics. The implications of these findings for the relation of focalized brain damage to intelligence is discussed.

A multicentre, randomised, controlled study compared the efficacy of l-alpha-glyceryl-phosphorylcholine (alpha GPC) and ST200 (acetyl-l-carnitine) among 126 patients with probable senile dementia of Alzheimer's type (SDAT) of mild to moderate degree. Efficacy was evaluated by means of behavioural scales and psychometric tests. The results showed significant improvements in most neuropsychological parameters in the alpha GPC recipients. Improvements also occurred in the ST200 recipients but to a lesser extent. Tolerability was good in both groups. These positive findings require replication in larger, double-blind, longitudinal studies coupling clinical and biological determinations.